David I. Hong

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “First, do NOHARM: a medical safety benchmark and randomized study of physician and AI teaming on clinical consultations”.

First, do NOHARM: a medical safety benchmark and randomized study of physician and AI teaming on clinical consultations

arXiv (Cornell University)(2025)10.48550/arxiv.2512.01241

N/A

0.335DataRank · unranked

5 citations

Fateme Nateghi Haredasht, Saloni Kumar Maharaj, Jain, Priyank, Jessica Tran, Matthew Gwiazdon +46 more

Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization

Annals of Allergy Asthma & Immunology(2021)10.1016/j.anai.2021.04.032

N/A

0DataRank · unranked

5 citations

Eleni Stavrou, David I. Hong, Nathan T. Connell, Paige G. Wickner, Katherine R. Tuttle

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.08.048

N/A

0DataRank · unranked

6 citations

Lacey B. Robinson, Lily Li, Matthew S. Krantz, Jason Kwah, Gilbert Ortega +17 more